Akli's third-quarter operating revenue was 168 million yuan, down 24.87 percent year on year
Wuxi Acoli, a domestic supplier of polyether amines, announced its third quarter 2022 financial results. In the third quarter, Akeli achieved operating income of 168 million yuan, decreasing 24.87% year on year, net profit attributable to the mother realized 29.64 million yuan, increasing 67.92% year on year, withholding non-net profit attributable to the mother 28.66 million yuan, increasing 68.76% year on year. From January to September this year, the first three quarters of Akli accumulated operating income of 577 million yuan, a year-on-year decrease of 9.73%, net profit to the mother of 104 million yuan, a year-on-year increase of 52.05%, deduction of non-maternal net profit of 102 million yuan, a year-on-year increase of 53.19%. In the other quarter to the third quarter, Arklee's cash flow from operating activities was 139 million yuan, an increase of 17.31% compared to the same period last year.
As for the decline in revenue, Acoli attributed the main reason to a slight decline in product sales due to the lack of road transportation during the pandemic. The increase of net profit is mainly due to the decrease of raw material prices and the increase of profit margin.
2026-08-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Paint Giant PPG Announces Global Price Hike
-
China National Salt Industry Corporation Advances 10,000 t/y Sodium Metal Expansion Project, Industry Leader Invests Nearly RMB 100 Million
-
Wanhua Chemical Announces 2026 Investment Plan: RMB 27.3 Billion for Projects Plus RMB 2.22 Billion for Equity Investments
-
BASF Raises API and Excipient Prices
-
DyStar Becomes a Wholly-Owned Subsidiary of Zhejiang Longsheng Group, Ending Longstanding Shareholder Disputes with a $5 Billion Deal
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
BASF Builds New Alkyl Polyglucoside Plant in Thailand, Expands Its Business Footprint in Asia
Recommend Reading
-
The Cost of 2,000 Jobs: How ExxonMobil Uses Layoffs to Announce a Global Chemical Map Reshuffle
-
BASF Brings Biomass-Balance Polyols to North America
-
Nouryon's Production Facilities in China Have Obtained Halal Certification for Personal Care Ingredients
-
When BASF Lets Agriculture Fly Solo: A Capital Repricing of Scale and Ambition
-
“Strategic Amputation” or “Phoenix Rebirth”? AkzoNobel’s Global Retreat and a $25 Billion Gamble
-
Cost Support Limited, Maleic Anhydride Prices in China Drop Significantly
-
On April 29, the market price of pure benzene in China was slightly increased
-
Polyethylene Prices Fall, Short-Term Fluctuations with a Weaker Trend
-
Supply and Demand Drag Down Methylene Chloride in a Cliff-like Decline
-
Multiple Negative Factors Weigh on Butadiene in April, Driving Prices Lower